Supriya Lifescience Limited (SUPRIYA) — Cash Flow Reinvestment Rate
Supriya Lifescience Limited (SUPRIYA) has a Cash Flow Reinvestment Rate of 0.76x as of September 2025, reinvesting Rs422.49 Million (capex Rs422.49 Million ) from operating cash flow of Rs555.65 Million. See Supriya Lifescience Limited free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Supriya Lifescience Limited Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Supriya Lifescience Limited across 8 annual periods. For the full cash flow conversion analysis, see SUPRIYA cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Supriya Lifescience Limited (2018–2025)
Year-by-year capital reinvestment analysis for Supriya Lifescience Limited. See Supriya Lifescience Limited financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.82x | Rs3.15 Billion | Rs1.73 Billion | Rs1.62 Billion | ▼ -35.3% |
| 2024 | 2.82x | Rs3.19 Billion | Rs1.13 Billion | Rs1.46 Billion | ▼ -22.8% |
| 2023 | 3.65x | Rs2.42 Billion | Rs661.87 Million | Rs1.08 Billion | ▲ +48.8% |
| 2022 | 2.45x | Rs1.20 Billion | Rs488.01 Million | Rs599.04 Million | ▲ +105.0% |
| 2021 | 1.20x | Rs956.51 Million | Rs799.30 Million | Rs482.41 Million | ▲ +183.2% |
| 2020 | 0.42x | Rs490.50 Million | Rs1.16 Billion | Rs245.25 Million | ▲ +193.3% |
| 2019 | 0.14x | Rs70.13 Million | Rs486.72 Million | Rs69.45 Million | ▼ -49.7% |
| 2018 | 0.29x | Rs49.98 Million | Rs174.52 Million | Rs49.30 Million | — |